Skip to content

Clinical trials

Completed Macular Degeneration trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Status: Completed Country / region: Czechia Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20081
20091
20101
20111
20153
20182
20193
20204
20211
20223
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Bayer2
Pfizer2
Allergan1
Alvotech Swiss AG1
Amgen1
Astellas Pharma Global Development, Inc.1
Bioeq GmbH1
Genentech, Inc.1
IVERIC bio, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration23
Geographic Atrophy6
Eye Diseases3
Retinal Diseases3
Vision Disorders3
Wet Macular Degeneration3
Choroidal Neovascularization2
Retinal Degeneration2
Blindness1
Retinal Vein Occlusion1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.